between January and June 2023
The trial enrolled 281 participants across 42 research and healthcare centers in the United States, randomized to once-weekly subcutaneous retatrutide (0.5, 4, 8, or 12 mg), once-weekly subcutaneous dulaglutide 1.5 mg (active comparator), or placebo, over a 36-week treatment period
Epithalon is usually run in short courses of about 10 to 20 days, repeated once or twice a year, rather than taken daily indefinitely
The ability of L-carnitine to reduce sebum production makes it of particular interest in acne management
It is expanding the GLP1 customer/patient base with 80% of patients new to therapy, driving economics into higher-priced doses, and optimistically starting to repair market confidence that was badly shaken by guidance cuts and competitive pressure from tirzepatide